JAZZ News and Press, Jazz Pharmaceuticals plc From 11/09/22

Jazz Pharmaceuticals plc (JAZZ) Q3 2022 Earnings Conference Call November 09, 2022 04:30 PM ET Company Participants Andrea Flynn - VP and Head, IR Bruce Cozadd - Chairman and CEO Dan Swisher - President Rob Iannone - EVP, Global Head of R&D Renée...

Jazz Pharmaceuticals ( NASDAQ: JAZZ ) updated full-year guidance includes an adjusted EPS estimate range that includes the consensus guidance. The company is expecting adjusted EPS of $17.20 to $17.85 (consensus $17.30). It also raised the midpoint of its revenue guidance ...

The following slide deck was published by Jazz Pharmaceuticals plc in conjunction with their 2022 Q3 earnings call. For further details see: Jazz Pharmaceuticals plc 2022 Q3 - Results - Earnings Call Presentation

Jazz Pharmaceuticals press release ( NASDAQ: JAZZ ): Q3 Non-GAAP EPS of $5.17 beats by $0.50 . Revenue of $940.65M (+12.2% Y/Y) in-line. FY2022 Outlook : Raising the mid-point of 2022 total revenue guidance to $3.65B driven by increases in the guidance mid...

Jazz Pharmaceuticals Announces Third Quarter 2022 Financial Results and Raises Total Revenue Guidance Mid-point PR Newswire DUBLIN , Nov. 9, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quart...

Jazz Pharmaceuticals to Present Data at 2022 ASH Meeting Showcasing Commitment to Advancing Oncology Research PR Newswire Key data includes results for intravenous administration of Rylaze ® (asparaginase erwinia chrysanthemi (recombinant)-rywn) in Acute Lymph...

Summary Cannabis stocks posted an all-time low in September. Sentiment is terrible. I think the future for the American cannabis industry is bright. Investors should, in my view, invest again or invest initially in cannabis stocks. The cannabis sector recently se...

Summary The lazy way to interpret the tech titans earnings reports last week is to say that Cloud Tech is over. It's not. We organize post market trading we call "fishing" we use it to try and acquire shares at the lowest prices. Alphabet, Amazon, and Microsoft will regain the...

Summary The macroeconomic factors create a highly favorable mergers and acquisition environment. Several interesting deals are being executed this month. As it's a strong buyers' market, you're likely to see more buyouts going toward year-end and next year. Axsome is an ideal ...

Jazz Pharmaceuticals to Report 2022 Third Quarter Financial Results on November 9, 2022 PR Newswire DUBLIN , Oct. 26, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2022 third quarter financial re...